Marijuana Co of America, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Psomiadis Themistocles, was filed 08 Dec 2020.
Marijuana Co of America, Inc.: what insiders have been doing
This page follows insider dealings at Marijuana Co of America, Inc. as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. The past year has been quiet: not a single insider filing for Marijuana Co of America, Inc. The previous disclosure was published on 29 November 2021.
Since 2017, the database holds 8 purchases and 480 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Xenon Pharmaceuticals Inc. and Vivos Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -68.1%Entry US$0.00 · Close at T+365 US$0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2021FY ended December 2021 · cache
- 3,966,666 shares@ US$0.0027.3% of flowCommonSEC:0001553350-21-001111:1
- 2,700,000 shares@ US$0.0025.4% of flowCommonSEC:0001553350-21-001111:0
- 26,315,789 shares@ US$0.003894.6% of flowCommon StockSEC:0001079973-21-000910:0
- 2,000,000 shares@ US$0.0085Common StockSEC:0001573281-21-000003:0
- 1,428,571 shares@ US$0.0082Common StockSEC:0001573281-21-000002:0
- 1,500,001 shares@ US$0.00115.3% of flowCommon StockSEC:0001573281-21-000001:0
- 1,500,001 shares@ US$0.0115Common StockSEC:0001573281-20-000006:0
- 1,500,001 shares@ US$0.0015.3% of flowCommon StockSEC:0001573281-20-000005:0Canonical exit: 3 Jan 2021 (T+90)
- 11,428,571 shares@ US$0.001455.9% of flowCommon StockSEC:0001573281-20-000004:0Canonical exit: 23 Feb 2021 (T+90)
- 1,500,001 shares0.5% of flowCommon StockSEC:0001573281-20-000003:0Canonical exit: 3 Jan 2021 (T+90)
- 7,784,818 shares@ US$0.001438.3% of flowCommon StockSEC:0001262463-20-000347:0
- 212,121 shares@ US$0.0032Common StockSEC:0001262463-20-000334:0
- 10,000,000 shares0Common StockSEC:0001262463-20-000295:0
- 220,879 shares@ US$0.0054CommonSEC:0001262463-20-000239:0
- 529,000 shares@ US$0.005CommonSEC:0001262463-20-000221:0
- 1,000,000 shares@ US$0.005Common StockSEC:0001262463-20-000220:0
- 12,000,000 shares@ US$0.01Common StockSEC:0001262463-20-000175:0
- 198,040 shares@ US$0.0658CommonSEC:0001262463-19-000458:0
- 100,000 shares@ US$0.0624CommonSEC:0001262463-19-000457:0
- 38,965 shares@ US$0.0673CommonSEC:0001262463-19-000457:1
- 40,000 shares@ US$0.146CommonSEC:0001262463-19-000423:0
- 43,138 shares@ US$0.137CommonSEC:0001262463-19-000423:1
- 34,403 shares@ US$0.133CommonSEC:0001262463-19-000423:2
- 100,000 shares@ US$0.0061CommonSEC:0001262463-19-000252:0
- 1,037,183 shares@ US$0.0059CommonSEC:0001262463-19-000252:1
25 of 492 declarations
About Marijuana Co of America, Inc.
Marijuana Co of America, Inc. is a U.S. micro-cap company operating in the cannabis and hemp space, and it is not a NYSE/NASDAQ large-cap story but rather a speculative small-company name in the U.S. public markets ecosystem. For French, Belgian, and Swiss investors, the company should be viewed primarily through the lens of regulation, financing risk, and execution risk. Historically, the business is a Utah corporation that pivoted its strategy in 2015 toward cannabis and legal hemp, and its principal business address has been disclosed in Los Angeles, California. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1078799/000107997322000450/mcoa_rega.htm?utm_source=openai))
The company’s SEC disclosures describe a business model built around two main pillars. First, MCOA has presented itself as an owner/operator of cannabis cultivation, processing, and dispensary facilities. Second, and more importantly from a commercial perspective, it has developed a hemp/CBD distribution platform through its wholly owned subsidiary cDistro, Inc., a Nevada corporation. According to the company’s filings and press materials, cDistro distributes hemp-derived cannabinoid products across the United States and supplies wholesalers, convenience stores, specialty retailers, and smoke/vape-related channels in North America. In practical terms, this makes the company more of a distribution-and-brands play than a scaled integrated cannabis operator. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1078799/000107997322000450/mcoa_rega.htm?utm_source=openai))
Read moreShow less
From a competitive standpoint, Marijuana Co of America remains a very small participant in a crowded U.S. hemp and cannabis market. It competes against much better capitalized public companies, private-label suppliers, and a fragmented wholesale channel. Its competitive edge, if any, is not scale but niche positioning, brand-building ambitions, and the ability to operate within the legal hemp framework under U.S. federal law. The company’s filings emphasize that marijuana remains heavily restricted under federal law, while hemp-derived products below the THC threshold are treated differently. That regulatory split is central to understanding the investment case, because it shapes product legality, interstate distribution, banking access, and partner risk. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1078799/000107997322000450/mcoa_rega.htm?utm_source=openai))
Geographically, the company is U.S.-focused, with operational references centered on Los Angeles and distribution activity across the United States. Its footprint is therefore domestic rather than international, although cDistro’s channel mix touches multiple retail formats in North America. Recent company-specific developments visible in public filings include continued reliance on the cDistro distribution platform and routine SEC reporting, alongside governance changes such as a 2023 board resignation. For investors, the key question is whether MCOA can build sustainable revenue streams and improve operating discipline before dilution, legal complexity, or market volatility erode shareholder value. In short, it is an ultra-small-cap U.S. cannabis/hemp story with high risk, limited scale, and a regulatory backdrop that remains fluid. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1078799/000107997321000583/ex99x1.htm?utm_source=openai))
